Sageworth Trust CO Novartis Ag Transaction History

Sageworth Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$80.52 - $93.75 $40,260 - $46,875	-500 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$80.11 - $90.62 $40,055 - $45,310	500 New	500 $44,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $39,850 - $44,065	-500 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$81.78 - $95.14 $40,890 - $47,570	500 New	500 $41,000
Q4 2019 Jan 28, 2020	SELL	$84.35 - $95.37 $42,175 - $47,685	-500 Closed	0 $0
Q3 2017 Oct 23, 2017	BUY	$74.14 - $77.27 $37,070 - $38,635	500	500 $43,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.